SeekingAlpha · Apr 3, 2026
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
On Thursday, news broke that the US will likely start levying a 100% tariff on branded pharmaceutical imports. Read more here.
FT
NASDAQ · FTXH
First Trust Nasdaq Pharmaceuticals ETF
Financial Services · Asset Management
$41.09
Down-$0.31 (-0.74%)
Updated Sep 19, 2026, 11:56 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 19.52M
- P/E ratio
- —
- Dividend yield
- 1.13%
- 52-week range
- $27.30 – $42.87
- Volume
- 29.56K
- Avg. volume
- 4.5K
Price performance
FTXH price history
1M range · 20 trading sessions · Daily adjusted prices
FTXH closed at $41.09 after 20 trading sessions, down 2.77% for the selected period.
- Last close
- $41.09
- Period change
- -2.77%
- Period low
- $40.47
- Period high
- $42.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $41.291 | $41.291 | $41.01 | $41.089 | 29.56K |
| Sep 17, 2026 | $41.13 | $41.4165 | $41.13 | $41.3957 | 25.1K |
| Sep 16, 2026 | $40.70 | $41.01 | $40.59 | $40.8348 | 29.76K |
| Sep 15, 2026 | $40.76 | $40.76 | $40.335 | $40.69 | 23.6K |
| Sep 14, 2026 | $40.73 | $40.89 | $40.57 | $40.72 | 9.3K |
| Sep 11, 2026 | $40.86 | $40.86 | $40.4101 | $40.4666 | 20.38K |
| Sep 10, 2026 | $40.78 | $40.78 | $40.3801 | $40.52 | 32.62K |
| Sep 9, 2026 | $40.81 | $41.015 | $40.63 | $40.6998 | 17.09K |
| Sep 8, 2026 | $41.20 | $41.20 | $40.85 | $40.91 | 44.08K |
| Sep 4, 2026 | $41.97 | $41.97 | $41.6773 | $41.7742 | 21.36K |
| Sep 3, 2026 | $42.40 | $42.40 | $41.71 | $42.2181 | 31.49K |
| Sep 2, 2026 | $42.27 | $42.27 | $41.71 | $42.1276 | 25.23K |
| Sep 1, 2026 | $41.70 | $41.73 | $41.36 | $41.6177 | 136.5K |
| Aug 31, 2026 | $41.005 | $41.415 | $40.8583 | $41.3525 | 53.24K |
| Aug 28, 2026 | $41.95 | $41.95 | $41.21 | $41.33 | 81.56K |
| Aug 27, 2026 | $42.00 | $42.13 | $41.8301 | $42.00 | 325.77K |
| Aug 26, 2026 | $42.55 | $42.55 | $42.20 | $42.2593 | 159.42K |
| Aug 25, 2026 | $42.24 | $42.82 | $42.24 | $42.7605 | 61.49K |
| Aug 24, 2026 | $42.22 | $42.26 | $41.74 | $42.2235 | 126.47K |
| Aug 21, 2026 | $41.7816 | $42.4199 | $41.7816 | $42.26 | 93.12K |
Latest FTXH news
The latest Smart Investors Daily articles mentioning FTXH.
Stock researchCompany · Overview
FTXH research
Overview
Company profile and research snapshot.
Company profile
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Mar 19, 2026
Europe's Last Chance To Revive Its Pharmaceutical Innovation Power
Europeâs pharmaceutical industry needs to make sure it doesn't become yesterday's news.
SeekingAlpha · Mar 13, 2026
Pharma's Godfather Moment: Pulled Back Into Tariff Uncertainty
The US Supreme Court invalidated President Trumpâs use of emergency authority to impose tariffs. Read more here.
Benzinga · Feb 4, 2026
What's Going On With Bristol-Myers Squibb Stock Today?
Bristol Myers stock is volatile ahead of earnings as investors weighed its expanded OXB manufacturing deal and recent bullish analyst commentary.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
